Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1625 1629
This examiner grants 61% of resolved cases
Jerica Katlynn Wilson is an examiner in Tech Center 1600 and Art Unit 1621, where she has 112 resolved cases. Her allowance rate of 60.7 percent indicates the likelihood of success for applicants. A feature of her profile is the interview lift of 39.3 percent. This lift suggests that interviews are effective at moving applications toward allowance when compared to the 60.7 percent allowance rate. The median days to allowance for this examiner is 1181.
This timeframe provides an expectation for the duration of the prosecution process from filing to grant. With 112 resolved cases, the data provides a foundation for understanding her examination style. Practitioners should consider scheduling interviews, given the 39.3 percent lift, to influence the chances of success. The 60.7 percent allowance rate and 1181-day median suggest that active engagement is a productive path forward.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18809439 | SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT | Non-Final OA | AbbVie Inc. |
| 18195134 | 1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER | Non-Final OA | Genentech, Inc. |
| 18312998 | IRON-COBALT-BASED MAGNETICALLY RECOVERABLE CATALYSTS AND METHOD OF PREPARATION THEREOF | Non-Final OA | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS |
| 18294441 | INHIBITORS OF 12/15-LIPOXYGENASE | Final Rejection | The Regents of the University of California |
| 18684053 | METHODS AND COMPOSITIONS FOR TREATING ALPHA-SYNUCLEIN-MEDIATED NEURODEGENERATION | Final Rejection | UNIVERSITY HEALTH NETWORK |
| 18862393 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY VASCULAR DISEASE | Non-Final OA | UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| 18697976 | COMPOSITIONS COMPRISING SMALL MOLECULE REGULATORS OF TUMOR IMMUNITY AND METHODS OF USING SAME | Non-Final OA | Duke University |
| 18249228 | Compositions and Uses Thereof | Final Rejection | Purposeful IKE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy